Sensitivity and specificity of planar scintimammography with 99mTc-sestamibi

Acta Radiologica

Volumn 40, Issue 4, 1999, Pages 394-399

  Danielsson, Rimma ^a   Bone B ^a   Gad, A ^a   Sylvan, M ^a   Aspelin, P ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Breast neoplasms; Diagnostic accuracy; Radionuclide studies

Indexed keywords

DIAGNOSTIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BREAST TUMOR; CANCER INVASION; CARCINOMA IN SITU; COMPARATIVE STUDY; FEMALE; FIBROADENOMA; FOLLOW UP; HUMAN; LUNG CARCINOMA; MAMMOGRAPHY; MASTECTOMY; MIDDLE AGED; OBSERVER VARIATION; PAGET NIPPLE DISEASE; PAPILLARY CARCINOMA; PROSPECTIVE STUDY; RADIOGRAPHY; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CARCINOMA, PAPILLARY; FEMALE; FIBROADENOMA; FOLLOW-UP STUDIES; HUMANS; MAMMOGRAPHY; MASTECTOMY; MIDDLE AGED; NEOPLASM INVASIVENESS; OBSERVER VARIATION; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI;

EID: 0033158696     PISSN: 02841851     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841859909177753     Document Type: Article

References (20)

1. ANDERSSON I., ANDRÉN L., HILDELL J. et al.: Breast cancer screening with mammography. A population-based, randomized trial with mammography as the only screening mode. Radiology 132 (1979), 273.
2. BOMBARDIERI E., CRIPPA F., MAFFIOLI L. & GRECO M.: Nuclear medicine techniques for the study of breast cancer. Eur J. Nucl. Med. 24 (1997), 809.
3. BUSCOMBE J. HILL J. & PARBHOO S.: Scintimammography. A guide to good practice. Gibbs Associates Ltd., Edgbaston House, UK 1998.
4. FRISELL J., GLAS U., HELLSTRÖM L. & SOMELL A.: Randomized mammographic screening for breast cancer in Stockholm. Breast Cancer Res. Treat. 8 (1986), 45.
5. GUPTA P., WAXMAN A., NGUYEN K. et al.: Correlation of Tc 99m sestamibi uptake with histopathological characteristics in patients with benign breast disease. J. Nucl. Med. 37 (1996), S 1122.
6. HELBICH T. H., BECHERER A., TRATTNIG S. et al.: Differentiation of benign and malignant breast lesions. MR imaging versus Tc-99m sestamibi scintimammography. Radiology 202 (1997), 421.
7. KHALKHALI I., CUTRONE J., MENA I. et al.: Technetium-99m-sestamibi scintimammography of breast lesions. Clinical and pathological follow-up. J. Nucl. Med. 36 (1995), 1784.
8. KHALKHALI I., IRANIHA S., DIGGLES L. E., CUTRONE J. A. & MISHKIN F. S.: Scintimammography. The new role of technetium-99m sestamibi imaging for the diagnosis of breast carcinoma. Q. J. Nucl. Med. 41 (1997), 231.
9. KHALKHALI I., VILLANUEVA-MEYER J., EDELL S. L. et al.: Diagnostic accuracy of Tc-99m sestamibi breast imaging in breast cancer detection. J. Nucl. Med. 37 Suppl. 287 (1996).
10. LASTORIA S., VARELLA P., MAINOLFI C. et al.: Tc-99m sestamibi scintigraphy in the diagnosis of primary breast cancer. (Abstract.) J. Nucl. Med. 35 (1994), 22 p N 79.
11. MAUBLANT J.: Scintigraphic imaging of breast tumors. Eur. J. Radiol. 24 (1997), 2.
12. MAURER A. H., CAROLINE D. F., JADALI F. J. et al.: Limitation of craniocaudal thallium-201 and technetium-99m-sestamibi mammography. J. Nucl. Med. 36 (1995), 1696.
13. PALMEDO H., BIERSACK H.-J., LASTORIA S. et al.: Scintimammography with technetium-99m methoxyisobutylisonitrile. Results of a prospective European multicentre trial. Eur. J. Nucl. Med. 25 (1998), 375.
14. PALMEDO H., SCHOMBURG A., GRUNWALD F., MALLMANN P., KREBS D. & BIERSACK H.-J.: Technetium-99m-MIBI scintimammography for suspicious breast lesions. J. Nucl. Med. 37 (1996), 626.
15. TABÁR L., FAGERBERG G., DUFFY S. W., DAY N. S., GAD A. & GRÖNTOFT O.: Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol. Clin. North Am. 30 (1992), 187.
16. TAILLEFER R., ROBIDOUX A., LAMBERT R., TURPIN S. & LAPIERRE J.: Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J. Nucl. Med. 36 (1995), 1758.
17. THURFJELL E.: Mammography screening methods and diagnostic results. Acta Radiol. (1995), Suppl. 395, p. 22.
18. TILING R., KHALKHALI I., SOMMERET H. et al.: Role of technetium-99m sestamibi scintimammography and contrast-enhanced magnetic resonance imaging for the evaluation of indeterminate mammograms. Eur. J. Nucl. Med. 24 (1997), 1221.
19. VILLANUEVA-MEYER J., LEONARD M. H., BRISCOE E. et al.: Mammoscintigraphy with technetium-99m-sestamibi in suspected breast cancer. J. Nucl. Med. 37 (1996), 926.
20. WAXMAN A., NAGARAJ N., ASNOK G. et al.: Sensitivity and specificity of Tc-99m methoxy-isobutyl isonitrile (MIBI) in the evaluation of primary carcinoma of the breast. Comparison of palpable and non-palpable lesions with mammography. (Abstract.) J. Nucl. Med. 35 (1994), 22 p N 78.